Citation Impact
Citing Papers
Collagen XXIII Expression Is Associated with Prostate Cancer Recurrence and Distant Metastases
2007
The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.
1994
Origins and evolution of the Western diet: health implications for the 21st century1,2
2005 Standout
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter
1990
Relationship between Disease Duration and Predominant Orbital T Cell Subset in Graves’ Ophthalmopathy
2000
The role of interleukin-1 in the pathogenesis of IDDM
1996
Transgenic overexpression of human Bcl-2 in islet β cells inhibits apoptosis but does not prevent autoimmune destruction
2000 StandoutNobel
Effects of thyroid hormone on the development of immune system in zebrafish
2005
Animal models of human disease: zebrafish swim into view
2007 Standout
Infection, Thyroid Disease, and Autoimmunity*
1993
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
2009 Standout
Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)
2016 StandoutNobel
Anti-β1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: Mapping of epitopes in the first and second extracellular loops
1995
Serum pituitary antibodies in normal pregnancy and in patients with postpartum thyroiditis: a nested case–control study
2008
B-cell depletion with rituximab in the treatment of autoimmune diseases
2007
Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells
2010 Standout
Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
2002 Standout
Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis
2004
Human Antibodies from Combinatorial Libraries
1994
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
TSH receptor gene expression in retroocular fibroblasts
1994
Irritable bowel syndrome
2016 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
Biology of Natural Killer Cells
1989 Standout
Extracellular matrix structure
2015 Standout
Graves' Ophthalmopathy
2010 Standout
The Collagen Family
2010 Standout
Adverse effects related to thionamide drugs and their dose regimen
1989
Thyroid Disease and Pregnancy
1991
Remodelling the extracellular matrix in development and disease
2014 Standout
Muscles of a different 'color'
1996
Reevaluating Thyrotropin Receptor-Induced Mouse Models of Graves’ Disease and Ophthalmopathy
2004
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Nicotinamide and 3‐aminobenzamide inhibit recombinant human interferon‐γ‐induced HLA‐DR antigen expression, but not HLA‐A, B, C antigen expression, on cultured human thyroid cells
1992
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Clinical Features of Patients with Graves' Disease Undergoing Remission After Antithyroid Drug Treatment
1997
Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy
2000
Stress and autoimmunity
2009
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
2009
Amino acids and immune function
2007 Standout
Stress System – Organization, Physiology and Immunoregulation
2006
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform 1 1Edited by M. Yaniv
1997 StandoutNobel
Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies
2017
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Treatment of Graves’ disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study
2007
Gene Map of the HLA Region, Graves’ Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation
2015
Iodine-deficiency disorders
2008 Standout
Pathogenesis of Graves' Ophthalmopathy
1993
Antineutrophil Cytoplasmic Antibody-Positive Vasculitis in A Patient with Graves Disease: Cross-Reaction Between Propylthiouracil and Methimazole
2010
Derivation of Functional Antagonists Using N-Terminal Extracellular Domain of Gonadotropin and Thyrotropin Receptors
1997 StandoutNobel
Temporal relationship between onset of Graves’ ophthalmopathy and onset of thyroidal Graves’ disease
1988
Treatment of Graves' disease and the course of ophthalmopathy
1989
Prevalence of thyroid disease and abnormal thyroid function test results in patients with systemic lupus erythematosus
1987
Clinical Utility of Thyrotropin-Receptor Antibody Assays: Comparison of Radioreceptor and Bioassay Methods
1988
Autoimmune thyroid disease: new models of cell death in autoimmunity
2002
No Immunological Benefit of Selenium in Consecutive Patients with Autoimmune Thyroiditis
2008
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Elephantiasic Pretibial Myxedema: Insight into and a Hypothesis Regarding the Pathogenesis of the Extrathyroidal Manifestations of Graves' Disease
2000
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein.
1996 StandoutNobel
Inhibition of Immunoglobulin-Secreting Cells by Antithyroid Drugs*
1981
Management of Graves’ Ophthalmopathy: Reality and Perspectives*
2000
Day-long glucose, insulin, and fructose responses of hyperinsulinemic and nonhyperinsulinemic men adapted to diets containing either fructose or high-amylose cornstarch
1989
The Prevalence of Thyroid-Stimulating Antibodies in Goitrous Disease Assessed by Cytochemical Section Bioassay*
1982
Nationwide survey of comorbidity, use, and costs of all medications in Finnish diabetic individuals.
2000
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
2007 Standout
Regulatory T Cells and Human Disease
2020 StandoutNobel
Changes in Thyroid-Stimulating Antibody Activity in Graves' Disease Treated with Antithyroid Drug and Its Relationship to Relapse: A Prospective Study*
1980
Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
2014 Standout
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
1977 Standout
ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY
1983 Standout
Impact of iodination on thyroid pathology in Africa
2006
Insight into Graves’ Hyperthyroidism from Animal Models
2005
Analysis of 754 Cases of Antithyroid Drug-Induced Agranulocytosis Over 30 Years in Japan
2013
Decreased Suppressor T-Lymphocytes in Autoimmune Thyroid Diseases Detected by Monoclonal Antibodies*
1982
The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency*
2000
Orbital Fibroblast Heterogeneity May Determine the Clinical Presentation of Thyroid-Associated Ophthalmopathy
2002
Autologous T-Lymphocytes Stimulate Proliferation of Orbital Fibroblasts Derived from Patients with Graves’ Ophthalmopathy
2005
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Natural killer cell activity in women at “high risk” for breast cancer, with and without benign breast syndrome
1984
Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease.
1985 StandoutNobel
The extracellular matrix at a glance
2010 Standout
Antithyroid Drug–Induced Agranulocytosis
1990
Three 15-min Bouts of Moderate Postmeal Walking Significantly Improves 24-h Glycemic Control in Older People at Risk for Impaired Glucose Tolerance
2013
Correlation between Thyrotropin-Displacing Activity and Human Thyroid-Stimulating Activity by Immunoglobulins from Patients with Graves' Disease and Other Thyroid Disorders*
1979
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Thyrotropin Receptor Autoantibodies Are Independent Risk Factors for Graves’ Ophthalmopathy and Help to Predict Severity and Outcome of the Disease
2006
Thyroid Hormone Regulation of Metabolism
2014 Standout
Gram-negative bacteremia
1980 Standout
Chimeric Antigen Receptor Therapy
2018 Standout
Therapeutic considerations
1978
Similar Effects of Thionamide Drugs and Perchlorate on Thyroid-Stimulating Immunoglobulins in Graves' Disease: Evidence against an Immunosuppressive Action of Thionamide Drugs
1984
Immunology of Autoimmune Thyroid Diseases
1982 Standout
Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center
2013
Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy
2003
Orbital Fibroblast Heterogeneity May Determine the Clinical Presentation of Thyroid-Associated Ophthalmopathy
2002
Diurnal and seasonal variation in oral glucose tolerance: Studies in the antarctic
1975
The safety and efficacy of antithyroid drugs
2005
Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
2016 Standout
T lymphocyte cytokine production patterns in hashimoto patients with elevated calcitonin levels and their relationship to tumor initiation.
2007
Effect of Abnormal Thyroid Function on the Severity of Graves' Ophthalmopathy
1990
Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO)
1997
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
THYROTROPHIN BINDING INHIBITING IMMUNOGLOBULINS IN GRAVES' DISEASE BEFORE, DURING AND AFTER ANTITHYROID THERAPY, AND ITS RELATION TO LONG‐ACTING THYROID STIMULATOR
1980
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
Relationship between silent thyroiditis and recurrent Graves' disease in the postpartum period.
1994
Autoimmunity in Endocrine Disease
1980
Pathophysiology of Graves’ Ophthalmopathy: The Cycle of Disease
2003
Cytokine Profiles in Eye Muscle Tissue and Orbital Fat Tissue from Patients with Thyroid-Associated Ophthalmopathy*
2000
Management of Graves' Ophthalmopathy: Reality and Perspectives
2000
Works of Jack R. Wall being referenced
Diurnal Variation in Glucose Tolerance: Associated Changes in Plasma Insulin, Growth Hormone, and Non-esterified
1974
Eye Muscle Antibodies in Patients with Ocular Myasthenia Gravis: Possible Mechanism for Eye Muscle Inflammation in Acetylcholine-Receptor Antibody-Negative Patients
1998
Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves’ ophthalmopathy receiving corticosteroid therapy
2003
Tissue Distribution and Quantitation of a Gene Expressing a 64-kDa Antigen Associated with Thyroid-Associated Ophthalmopathy
1996
Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid‐associated ophthalmopathy
1988
Role of the Eye Muscles in Thyroid Eye Disease: Identification of the Principal Autoantigens
1998
Thyroid-associated ophthalmopathy — a model for the association of organ-specific autoimmune disorders
1991
Patients with Endocrine Ophthalmopathy not Associated with Overt Thyroid Disease Have Multiple Thyroid Immunological Abnormalities*
1990
Serum Antibodies against the Flavoprotein Subunit of Succinate Dehydrogenase Are Sensitive Markers of Eye Muscle Autoimmunity in Patients with Graves’ Hyperthyroidism1
1999
Serum antibodies to collagen XIII: a further good marker of active Graves’ ophthalmopathy
2004
The Study of Visual Evoked Potentials in Patients with Thyroid-Associated Ophthalmopathy Identifies Asymptomatic Optic Nerve Involvement1
1997
Susceptibility genes in Graves’ ophthalmopathy: searching for a needle in a haystack?
2007
Thyroid-Associated Ophthalmopathy in Black South African Patients with Graves' Disease: Relationship to Antiflavoprotein Antibodies
1998
Time course of Graves’ ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study
2011
Reevaluation of the Prevalences of Serum Autoantibodies Reactive with "64-kd Eye Muscle Proteins" in Patients with Thyroid-Associated Ophthalmopathy
1998
Role of Autoantibodies in the Pathogenesis and Association of Endocrine Autoimmune Disorders*
1988
Detection of anti-pituitary autoantibodies by immunoblotting
1993
Autoantibodies Reactive with Extracellular Matrix Proteins in Patients with Thyroid-Associated Ophthalmopathy
1999
Pathogenesis of Thyroid-Associated Ophthalmopathy: An Autoimmune Disorder of the Eye Muscle Associated with Graves' Hyperthyroidism and Hashimoto's Thyroiditis
1993
Serum Antibodies Reactive with Eye Muscle Membrane Antigens Are Detected in Patients with Nonspecific Orbital Inflammation
1995
A Thyroid Cytotoxic Antibody That Cross-reacts With an Eye Muscle Cell Surface Antigen May Be the Cause of Thyroid-Associated Ophthalmopathy*
1988
Thyroid-Associated Ophthalmopathy: Clinical Features, Pathogenesis, and Management
2000
Expression of the Hermes-1 (CD44) and ICAM-1 (CD54) Molecule on the Surface of Thyroid Cells from Patients with Graves' Disease
1993
The Ocular Muscle Cell Is a Target of the Immune System in Endocrine Ophthalmopathy
1995
Type 2 diabetes does not predict incident thyroid dysfunction in the elderly
2008
Prevalence of Antibodies Reactive with a 64 kDa Eye Muscle Membrane Antigen in Thyroid-Associated Ophthalmopathy
1991
Study of Serum Antibodies Against Three Eye Muscle Antigens and the Connective Tissue Antigen Collagen XIII in Patients with Graves' Disease With and Without Ophthalmopathy: Correlation With Clinical Features
2006
Stress and Thyroid Autoimmunity
2004
In VitroImmunoreactivity to Propylthiouracil, Methimazole, and Carbimazole in Patients with Graves’ Disease: A Possible Cause of Antithyroid Drug-Induced Agranulocytosis*
1984
The 64-Kilodalton Eye Muscle Protein Is the Flavoprotein Subunit of Mitochondrial Succinate Dehydrogenase: The Corresponding Serum Antibodies Are Good Markers of an Immune-Mediated Damage to the Eye Muscle in Patients with Graves’ Hyperthyroidism1
1998
Antibodies in the Serum of Patients with Autoimmune Thyroid Disorders React with a Recombinant 98 Amino Acid Fragment of a Full Length 64 KDA Eye Muscle Membrane Protein which is also Expressed in the Thyroid
1992
Thyroid-associated ophthalmopathy ? a model for the association of organ-specific autoimmune disorders
1991
Natural cytotoxicity of peripheral blood leukocytes from normal subjects and patients with Hashimoto's thyroiditis against human adult and fetal thyroid cells
1983
THE IN VITRO SUPPRESSION OF LECTIN INDUCED3H-THYMIDINE INCORPORATION INTO DNA OF PERIPHERAL BLOOD LYMPHOCYTES AFTER THE ADDITION OF PROPYLTHIOURACIL.
1976
Evaluation of an enzyme-linked immunosorbent assay for the measurement of autoantibodies against eye muscle membrane antigens in Graves' ophthalmopathy
1986
Isolation and characterization of mononuclear cells from various thyroid tissue specimens
1983
Peripheral Blood and Intrathyroidal Mononuclear Cell Populations in Patients with Autoimmune Thyroid Disorders Enumerated using Monoclonal Antibodies*
1983
Immunologically Mediated Cytotoxicity against Human Eye Muscle Cells in Graves’ Ophthalmopathy*
1986
Experimental Model for Ophthalmopathy in BALB/c and Outbred (CD-1) Mice Genetically Immunized with G2s and the Thyrotropin Receptor
2002
Graves' hyperthyroidism and ophthalmopathy following treatment of spontaneous hypothyroidism with levothyroxine.
1981
Thyroid-Stimulating Antibodies in Patients with Autoimmune Disorders
1978
Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens.
1996
Eye muscle antibodies in Graves’ ophthalmopathy: Pathogenic or secondary epiphenomenon?
2004
THYROID BINDING ANTIBODIES AND OTHER IMMUNOLOGICAL ABNORMALITIES IN PATIENTS WITH GRAVES’OPHTHALMOPATHY: EFFECT OF TREATMENT WITH CYCLOPHOSPHAMIDE
1979
Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
1985
Cloning and Characterization of the Novel Thyroid and Eye Muscle Shared Protein G2s: Autoantibodies against G2s Are Closely Associated with Ophthalmopathy in Patients with Graves’ Hyperthyroidism
2000
EFFECTS OF EXPERIMENTAL HYPER- AND HYPOTHYROIDISM ON NUMBERS OF BLOOD MONONUCLEAR CELLS AND IMMUNE FUNCTION IN RATS AND GUINEA-PIGS
1981
Nature of Thyrotropin Displacement Activity in Subacute Thyroiditis*
1982
Multi‐System Immunologically Mediated Disease: T Lymphocyte Deficiency and Thyroid Immunologic Disease—A Report of Four Cases
1978
Cytotoxic Mechanisms in Autoimmune Thyroid Disorders and Thyroid-associated Ophthalmopathy
1987
Graves' ophthalmopathy.
1981
Native gel electrophoresis and isoelectric focusing of a 64-kilodalton eye muscle protein shows that it is an important target for serum autoantibodies in patients with thyroid-associated ophthalmopathy and not expressed in other skeletal muscle.
1995
Luekocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves’ ophthalmopathy
1979
THYROID STIMULATING ANTIBODIES IN PATIENTS WITH SUBACUTE THYROIDITIS.
1978
Lymphocyte Transformation in Response to Human Thyroid Extract in Patients with Subacute Thyroiditis
1976
Antibody-Dependent Cell Mediated Cytotoxicity against Human Thyroid Cells in Hashimoto's Thyroiditis but Not Graves' Disease*
1984